ARCHIVES

Center Core Grant Guidelines Changes Approved By NCAB

This article is from The Cancer Letter archive.

Vol. 07 No. 07 | February 13, 1981

Download PDF Visit The Full Archive

Related Articles

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013